Aim: Intra-operative cardiac output (CO) monitoring became a standard of care in Northampton General Hospital, UK, at the end of 2013. This study aimed to assess the effectiveness of intra-operative CO monitoring with oesophageal Doppler or LiDCO for patients undergoing elective colorectal surgery for cancer within an enhanced recovery after surgery (ERAS).
INTRODUCTION
Intra-operative cardiac output (CO) monitoring facilitates goal-directed intra operative fluid therapy (GDFT), a constituent of enhanced recovery pathways, which using a series of pre-, intra-and post-operative guidelines [1] , has been shown to improve patient recovery after major surgery. These programmes have been shown to reduce the length of hospital stay, readmissions, and 30-day morbidity [2] [3] [4] [5] [6] [7] [8] .
Intra-operative fluid administration is important in preventing hypovolaemia and its complications including hypo-perfusion, impaired wound healing, anastomotic leak [9, 10] and a systemic inflammatory response [2] , but there has been much debate in the literature about which intra-operative fluid (IOF) regimen is best for patients undergoing both open and laparoscopic colorectal surgery, with many advocating restrictive, more liberal or goal-directed fluid regimens with the aim of improving patient outcomes.
Restrictive regimens have been shown to be advantageous, reducing post-operative complications [11] [12] [13] [14] [15] , whereas liberal fluid administration has been associated with fluid overload and complications such as a reduction in gut motility, mucosal oedema and an increased risk of anastomotic breakdown [16, 17] . It is also associated with pulmonary oedema and cardiac dysrhythmias [15, [18] [19] [20] . GDFT aims to use dynamic measurements of cardiac output to guide IOF administration to maintain a "zero fluid balance" and thus reduce complications associated with inappropriate peri-operative fluid administration.
GDFT is achieved by monitoring cardiac output through various techniques, including the gold standard -pulmonary artery catheter-based thermodilution, but this is an invasive procedure associated with complications such as perforation of the pulmonary artery [21] . Vital sign measurements such as blood pressure and heart rate are not adequately specific or sensitive to guide fluid administration. Central venous pressure (CVP) monitoring has also been used, but this is limited in colorectal surgery where the patient is in the Trendelenburg position, creating a falsely elevated CVP by raising intrathoracic pressure, and has been shown to be an ineffective guide for IOF therapy [22] . Other techniques of continuous CO monitoring include oesophageal Doppler (CardioQ, Deltex Medical Ltd, Chichester, UK) and arterial pressure (AP) waveform analysis (LiDCO, LiDCO Ltd, Cambridge, UK) amongst others [23, 24] .
Although there are many studies assessing the value of restrictive or liberal fluid regimens, further investigation into the role of GDFT and CO monitoring in intraoperative fluid administration and its role on patient outcomes is needed.
The aim of this study was to compare the surgical outcome measures between 2 groups of patients (those who received intra-operative CO monitoring using the oesophageal Doppler or LiDCO and those who had no intraoperative CO monitoring) who underwent elective colorectal surgery in an enhanced recovery programme.
METHODS
Data was prospectively collected over a 5-year period (March 2010 -Feb 2015) for patients undergoing elective colorectal surgery in a single surgeon's practice. Data collection and analysis were performed by two observers. Surgical outcome measures included 30-and 90-day mortality, morbidity, readmission, length of hospital stay (LOS) and admission to a high level care facility [intensive care unit (ICU) or high dependency unit (HDU)]. With the introduction of intra-operative cardiac output monitoring with either oesophageal Doppler or LiDCO as a standard of care in patients on the ERAS pathways at the end of 2013, we compared outcomes to those where no intra-operative cardiac output monitoring was used prior to this time. All the patients were cared for on the enhanced recovery after surgery (ERAS) pathways. Statistical analysis and inter-group comparisons were made using the Mann-Whitney U test. A P-value of < 0.05 was deemed statistically significant.
RESULTS
Two-hundred and thirty nine patients were reviewed (intra-operative CO monitoring, n = 69 and no intraoperative CO monitoring, n = 144). Post-operative outcomes were analysed. Most baseline characteristics were similar for both groups of patients [ Table 1 ]. There was a statistically significant higher number of patients undergoing open surgery in the group with no intra-operative cardiac output monitoring (P = 0.05). There was also a statistically significant increase in the number of patients who had surgery for cancer in this group (P = 0.05). The greater number of patients in this group may explain this finding.
Only one patient died in this cohort within 30 days (in the no intra-operative CO monitoring group). There was no significant difference in the 30-day Clavien-Dindo morbidity (III-IV) for the two groups (5.7 vs. 5.5, P = 0.13). The median length of post-operative hospital stay for the treatment group was 6 days in comparison with 7 days for the control group. The difference in length of post-operative hospital stay between both groups was not statistically significant (P = 0.059). There was no statistically significant difference in 30-day readmission rate for both groups (10.1% vs. 5.5%) (P = 0.064).
A significantly higher proportion of patients (46.5%) were admitted to level 2/3 care facility for patients in the treatment group in comparison with patients in the control group (24%, P = 0.01) [ Table 2 ]. Twenty-four percent of patients were admitted to high dependency unit (level 2 care) in the treatment group whereas 39% of patients were admitted to level 2 care facility in control group. The median length of stay (2 days) in the high dependency unit (level 2 care) remained the same for both groups. No patients in the treatment group were admitted to the ICU. However, 11 patients (7.6%) were admitted to ICU in the control group.
DISCUSSION
The study found that patients with intra-operative cardiac output monitoring and goal directed fluid therapy had a reduced number of admissions to levels 2 and 3 care compared with patients receiving no intra-operative CO monitoring or GDFT. HDU admissions were 24% in the treatment group and 39% in the control group. No patients were admitted to ICU in the treatment group whereas 7.6% of patients were admitted to ICU in the control group. This could be due to several reasons: firstly, it may be that patients with intraoperative CO monitoring received optimised fluid therapy and subsequently required lower level of care, but the lack of data for the volumes of fluid administered to all patients leaves us unable to draw this conclusion. Secondly, CO monitoring provided the anaesthetists with up-to-date and accurate data about cardiovascular status and stability and may have influenced the need for postoperative care, hence, patients who were performing well having their care needs downgraded. Thirdly, adequate fluid administration intraoperatively would have reduced GI complications resulting from fluid overload or hypovolaemia. Fluid overload can lead to several harmful effects such as, generalised oedema, hindering tissue healing, detrimental effects on cardio-pulmonary functions, delayed recovery of gut functions [9] , decreased muscular oxygen tension [10] , increased risk of complications [11, 12] and is linked to poor survival rates [13] . The effectiveness of intra-operative cardiovascular monitoring to reduce such complications has been proven in other published studies [25] [26] [27] [28] [29] [30] . On the other hand, hypovolemia can lead to hypoperfusion, circulatory collapse, impaired wound healing, anastomotic leak [14, 15] , bacterial translocations and endotoxaemia with activation of the systemic inflammatory response [31] ; all of which account for the need of prolonged stay in high level care facilities post-operatively. Noblett et al. [2] have shown a reduction in peak systemic inflammatory cytokine (IL-6) levels for patients undergoing CO monitoring with Doppler. This study concluded that the Doppler intervention reduced the systemic inflammatory response to surgical trauma, preserved splanchnic perfusion and thereby reduced gut-related inflammatory responses. Fourthly, results could also have been affected by the fact that, within the control group, more patients had open surgical procedures for malignancy, and many cases were converted to open (n = 27), thus those patients, subsequently, required more HDU/ICU admissions. Therefore, the availability of intra-operative CO data in that patient group would have influenced the decision for admission to HDU/ICU care is not known.
The median length of hospital stay for treatment group was shorter in comparison to control group (6 vs. 7 days). But, this difference did not reach statistical significance (P = 0.078). All patients in the treatment and control groups were cared for on the ERAS programme. Outcomes associated with ERAS are dependent on multiple peri-operative factors.
The limitations of this study are a lack of data about the accurate volume of intra-operative fluids administrated, intra-operative CO variations, P-POSSUM scores and the rationale of the decision for admission to different levels of post-operative care areas. Availability of such data would have allowed adjusting for these confounding factors to assess post-operative outcomes more accurately. This study lacks the data about study population representative for other surgeons, variability in ethnicity and socioeconomic status. More patients in the control period had open operations and more had conversions from laparoscopic to open procedures that during the CO measurement period. Patients in the earlier period may have required more advanced care because of the higher level of invasiveness of the operation. These differences alone would explain a large percentage of the change in level 2/3 care required in the earlier period, and not the implementation of CO monitoring. Due to the lack of data about the precise decision for admission in ICU/ HDU in the control group did not allow analysis for these co-founders. The authors did not notice a change in practice for the use of bowel preparation for colon surgery patients. No mechanical bowel preparation is used at the unit for right colonic surgery and only Phosphate enema is used for left sided colonic and rectal surgery. Enhanced recovery protocols have recommended the elimination of mechanical bowel preparation which would reduce IV volume support for patients undergoing colorectal surgery. Though practice for bowel preparation did not change in study period, a lack of data in the consistency in bowel preparation over the entire time of the study highlights the issue that even a minor change in practice combined with less invasive surgical procedures makes the postoperative care of the patients in the two periods of time very different.
Intra-operative indices of tissue hypo-perfusion resulting in gastrointestinal dysfunction are the most common post-operative complications in patients undergoing moderate-to high risk emergency GI surgery. Intra-operative CO optimisation and GDFT for patients undergoing colorectal surgery reduces the postoperative morbidity, mortality and length of hospital stay [9] . GDFT has also been shown to be cost effective in reducing hospital stays and the surgical complications [32, 33] . It would be interesting to extend this study to use intra-operative cardiac output monitoring for patients undergoing emergency laparotomy and to assess the outcomes through the National Emergency Laparotomy Audit.
In conclusion, the use of intra-operative cardiac monitoring does not significantly alter the immediate postoperative outcomes; however, it reduces the need for admission to level 2/3 care facilities post-operatively. Intra-operative cardiac output monitoring might become an effective way to reduce the need for higher level critical care beds in patients undergoing elective colorectal surgery. A larger cohort study is needed to further confirm these findings and account for any co-founders. None.
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